These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7575)

  • 1. Determinants of lung bacterial clearance in normal mice.
    Jay SJ; Johanson WG; Pierce AK; Reisch JS
    J Clin Invest; 1976 Apr; 57(4):811-7. PubMed ID: 7575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of lung bacterial clearance in mice after acute hypoxia.
    Harris GD; Johanson WG; Pierce AK
    Am Rev Respir Dis; 1977 Oct; 116(4):671-7. PubMed ID: 21603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability of airborne Klebsiella pneumoniae to colonize mouse lungs.
    Bolister NJ; Johnson HE; Wathes CM
    Epidemiol Infect; 1992 Aug; 109(1):121-31. PubMed ID: 1499666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial growth in vivo. An important determinant of the pulmonary clearance of Diplococcus pneumoniae in rats.
    Johanson WG; Stephen JJ; Pierce AK
    J Clin Invest; 1974 May; 53(5):1320-5. PubMed ID: 4151066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of etiologic agents and antibiotic resistance in children with acute lower respiratory tract infection in Wenzhou City].
    Dong L; Zhou XC; Chen XF; Yang JH; Lin J; Zhang HL; Cai XH; Luo YC; Zhang ZX; Li CC
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):369-72. PubMed ID: 17052392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in initial rate of intracellular killing of Salmonella typhimurium by resident peritoneal macrophages from various mouse strains.
    van Dissel JT; Leijh PC; van Furth R
    J Immunol; 1985 May; 134(5):3404-10. PubMed ID: 3920318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pneumoniae pneumonia in mice: optimal amoxicillin dosing predicted from a pharmacokinetic-pharmacodynamic model.
    Moine P; Mazoit JX
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1086-92. PubMed ID: 10565828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between quinolone exposures and resistance amplification is characterized by an inverted U: a new paradigm for optimizing pharmacodynamics to counterselect resistance.
    Tam VH; Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Feb; 51(2):744-7. PubMed ID: 17116679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases.
    Zuluaga AF; Salazar BE; Rodriguez CA; Zapata AX; Agudelo M; Vesga O
    BMC Infect Dis; 2006 Mar; 6():55. PubMed ID: 16545113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of post-antibiotic lag and repair-recovery to the post-antibiotic effects of ciprofloxacin on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1993; 39(1):22-31. PubMed ID: 8444058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different application volumes of ethyl-cyanoacrylate tissue adhesive can change its antibacterial effects against ocular pathogens in vitro.
    Romero IL; Paiato TP; Silva CB; Nigro JB; Malta S; Jenne Mimica LM; Soong HK; Hida RY
    Curr Eye Res; 2008 Oct; 33(10):813-8. PubMed ID: 18853314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E; Dalhoff A; Korfmann G
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenic bacteria of childhood lower respiratory tract infection].
    Hua CZ; Yu HM; Chen ZM; Li JP; Shang SQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):365-8. PubMed ID: 17052391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A radiolabel ratio method for measuring pulmonary clearance of intratracheal bacterial challenges.
    LaForce FM; Boose DS
    J Lab Clin Med; 1988 Feb; 111(2):158-65. PubMed ID: 3276799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic-resistance in Italy: activity of the first year of the surveillance project AR-ISS].
    Boccia D; D'Ancona F; Salmaso S; Monaco M; Del Grosso M; D'Ambrosio F; Giannitelli S; Lana S; Fokas S; Pantosti A;
    Ann Ig; 2005; 17(2):95-110. PubMed ID: 16676730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postantibiotic effects of eleven antimicrobials on five bacteria.
    Wang MG; Zhang YY; Zhu DM; Zhang J; Shi YG
    Acta Pharmacol Sin; 2001 Sep; 22(9):804-8. PubMed ID: 11749860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung bacterial clearance in murine pneumococcal pneumonia.
    Ansfield MJ; Woods DE; Johanson WG
    Infect Immun; 1977 Jul; 17(1):195-204. PubMed ID: 18404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary cell response patterns after exposure to airborne bacteria.
    Rylander R; Snella MC; Garcia I
    Scand J Respir Dis; 1975; 56(4):195-200. PubMed ID: 812179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.